Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effects
Matthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
Nature Communications
|
November 17, 2023
Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids
Marc Oeller, Ryan J D Kang, Hannah L Bolt, et al.
Journal of Medicinal Chemistry
|
February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile
Lena Ripa, Karl Edman, Matthew Dearman, et al.
Journal of Medicinal Chemistry
|
August 16, 2019
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1<i>S</i>,2<i>S</i>)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
Magnus Munck Af Rosenschöld, Petra Johannesson, Antonios Nikitidis, et al.
Journal of Medicinal Chemistry
|
June 3, 2021
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
Matthew W D Perry, Karin Björhall, Peter Bold, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Bioorganic & Medicinal Chemistry Letters
|
May 15, 2022
Surprising lipophilicity observations identify unexpected conformational effects
Matthew W D Perry, Ulf Börjesson, Antonios Nikitidis, et al.
Nature Communications
|
November 17, 2023
Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids
Marc Oeller, Ryan J D Kang, Hannah L Bolt, et al.
Journal of Medicinal Chemistry
|
February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect Profile
Lena Ripa, Karl Edman, Matthew Dearman, et al.
Journal of Medicinal Chemistry
|
August 16, 2019
Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1<i>S</i>,2<i>S</i>)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma
Magnus Munck Af Rosenschöld, Petra Johannesson, Antonios Nikitidis, et al.
Journal of Medicinal Chemistry
|
June 3, 2021
Discovery of AZD8154, a Dual PI3Kγδ Inhibitor for the Treatment of Asthma
Matthew W D Perry, Karin Björhall, Peter Bold, et al.
Page
of 1